An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
基本信息
- 批准号:10205754
- 负责人:
- 金额:$ 15.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAdmission activityAdvance Care PlanningAdvance DirectivesAffectAnxietyAreaBehaviorBelief SystemCOVID-19COVID-19 pandemicCaregiversCaringCessation of lifeCharacteristicsChronic DiseaseCluster randomized trialComplexConflict (Psychology)Control GroupsDataDecision MakingDisastersDisease OutbreaksEducational BackgroundEnd stage renal failureEthnic OriginExhibitsFamilyFrightGenderGoalsHealthHealthcareHospitalizationIncomeIndividualInfectionInterventionLearningLifeLiteratureLongitudinal cohort studyMeasuresMedicalModelingNatural DisastersOutcomePanicPaperParentsPatient RecruitmentsPatientsPerceptionQuestionnairesRaceReadinessReflex actionResearchResourcesRiskSocial ChangeSocioeconomic StatusSpecific qualifier valueStressTimeUncertaintyUpdateWithdrawalaggressive therapybasebehavioral economicsbehavioral/social sciencecare outcomescare preferencecognitive performancecoronavirus diseaseeconomic impacteffectiveness implementation trialend of lifeend of life careend-of-life decision makingevidence baseexperiencefollow-upgroup interventionhigh riskinterestmultiple chronic conditionsnovelpandemic diseasepost interventionpreferencepsychologicrecruitresilienceresponserisk perceptionsexsocialsocial health determinantssociodemographics
项目摘要
ABSTRACT
This R01 supplement submitted in response to NOT-OD-20-097, Research on the 2019 Novel Coronavirus
and the Behavioral and Social Sciences, addresses one of the four focused areas specified in the notice: to
examine “downstream health impacts resulting from social, behavioral, and economic impacts, including
differences in risks and resiliency based on gender, race and ethnicity, socioeconomic status, and other social
determinants of health.” The COVID pandemic has brought fear and uncertainty to all aspects of life and
especially to medical care. Research has shown that after experiencing a natural disaster, people exhibit more
risk averse behaviors, and that belief systems can change: people “update” their perception of background risk
and perceive the world to be a much riskier place. Although studies have shown that values and preferences
for end-of-life care are stable over time especially after individuals made an effort to actively think about their
end-of-life preferences, another body of literature suggests that abrupt and disturbing social changes, such as
disasters, can affect the psychological mechanisms underlying cognitive performance. The effects of a
disaster may bring doubt to clinicians as well as to families regarding how to interpret an advance directive or
end-of-life care preferences that were expressed some time prior to the pandemic. There is very little empirical
data to guide advance care planning (ACP) with our sickest patients in the setting of a disaster and especially
one that is so novel. Therefore, we seek to learn whether in the setting of this novel disaster patients with
serious chronic illness are more or less likely to want aggressive treatment. This supplement research is to
generate new empirical data on the impact of the COVIDE-19 pandemic on patients' end-of-life preferences, to
address whether the stability of preferences is disrupted by the pandemic, and to identify patient
characteristics, including race/ethnicity, associated with pre-/post-pandemic changes. We will leverage the
parent study (R01NR017018), a cluster randomized trial of an evidence-based ACP intervention (SPIRIT), in
which we are currently following 143 dyads (65% Blacks) who successfully completed both the baseline and 2-
week post-intervention follow-up before the outbreak. In this new longitudinal cohort study, we will recruit 100
dyads from the pool of 143 to repeat the study assessment battery 2 more times along with new COVID-19
Stress Scales. The specific aims are to: 1) compare the stability of patients' goals-of-care preferences over
time, from pre-outbreak to during-outbreak, by group (SPIRIT vs control) and estimate effect by race (Blacks
and Whites); 2) assess the stability in the preparedness outcomes (dyad congruence, patient decisional
conflict, and surrogate decision-making confidence) comparing pre-outbreak to during-outbreak by group, and
estimate race effect; and 3) examine the associations of the COVID-19 Stress, sex, race/ethnicity, and other
sociodemographic characteristics (e.g., education level, income) to change in the outcomes and the stability of
patients' goals-of-care preferences after the COVID-19 outbreak.
抽象的
此R01补充是针对NOT-OD-20-097提交的,2019年小说冠状病毒的研究
以及行为和社会科学,介绍了通知中指定的四个重点领域之一:
检查“社会,行为和经济影响造成的下游健康影响,包括
基于性别,种族和种族,社会经济地位以及其他社会的风险和弹性差异
健康的决定因素。
特别是医疗保健。研究表明,经历了自然灾害后,人们暴露了更多
风险避开行为,而信仰体系可能会改变:人们“更新”对背景风险的看法
并认为世界成为一个风险更大的地方。尽管研究表明价值和偏好
因为寿命末护理会随着时间的流逝而稳定,尤其是在个人努力积极思考自己的
临终偏好,另一种文献表明,突然和令人不安的社会变化,例如
灾难会影响认知表现的心理机制。一个
灾难可能会对临床医生以及家庭对如何解释提前指令或
大流行前一段时间表达的临终护理偏好。几乎没有经验
与我们最恶心的患者一起在灾难的情况下,特别是
一个如此新颖。因此,我们试图了解在这个新颖的灾难患者的环境中
严重的慢性病或多或少需要积极治疗。这项补充研究是
生成有关Covide-19大流行对患者终止偏好的影响的新经验数据,
解决偏好的稳定性是否因大流行而禁用,并确定患者
特征,包括种族/民族,与大流行前变化有关。我们将利用
家长研究(R01NR017018),一项基于证据的ACP干预(精神)的聚类随机试验
我们目前正在遵循143个二元组(65%的黑人),他们成功完成了基线和2--
爆发前干预后的随访。在这项新的纵向队列研究中,我们将招募100
从143池的二元组重复研究评估电池2次,以及新的Covid-19
压力尺度。具体目的是:1)比较患者护理目标的稳定性
时间,从爆发前到爆发期间,按小组(精神与控制)和种族估计效应(黑人
和白人); 2)评估制备结果的稳定性(二元组合,患者决策
冲突和代孕决策信心)将爆发前爆发与小组爆发期间进行比较,
估计竞赛效应; 3)检查COVID-19压力,性别,种族/种族和其他的关联
社会人口统计学特征(例如,教育水平,收入)改变结果和稳定性
COVID-19-19爆发后患者的护理偏好。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MI-KYUNG SONG其他文献
MI-KYUNG SONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MI-KYUNG SONG', 18)}}的其他基金
Center for the Study of Symptom Science, Metabolomics and Multiple Chronic Conditions
症状科学、代谢组学和多种慢性病研究中心
- 批准号:
9763654 - 财政年份:2018
- 资助金额:
$ 15.6万 - 项目类别:
An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
- 批准号:
10361836 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
- 批准号:
9301866 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
Preparation for End of Life Decision Making in Mild Alzheimer's Disease
轻度阿尔茨海默病临终决策的准备
- 批准号:
9922847 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
An Effectiveness-Implementation Trial of SPIRIT in ESRD
SPIRIT 在 ESRD 中的有效性实施试验
- 批准号:
9890004 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
Preparation for End of Life Decision Making in Mild Alzheimer's Disease
轻度阿尔茨海默病临终决策的准备
- 批准号:
9423416 - 财政年份:2017
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8521388 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8257799 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8725529 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
Mapping Multidimensional Illness Trajectories of Patients With ESKD
绘制 ESKD 患者的多维疾病轨迹
- 批准号:
8339362 - 财政年份:2011
- 资助金额:
$ 15.6万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
- 批准号:
10495114 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Resources, Workforce Development, and Animal Models for the Rutgers RBL
罗格斯大学 RBL 的资源、劳动力发展和动物模型
- 批准号:
10793863 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Potential role of skin in SARS-CoV-2 infection
皮肤在 SARS-CoV-2 感染中的潜在作用
- 批准号:
10593622 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
- 批准号:
10748433 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别: